PTC Inc.
PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2026 RESULTS
PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year ended September 30, 2026. Fourth Fiscal Quarter…
Category
Earnings & Investor News press releases
341 releases
Kailera Therapeutics, Inc.
Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates
Ribupatide oral global Phase 3 program expected to begin in 1H 2027 following completion of End-of-Phase 2 meeting with FDA
Mativ Holdings, Inc.
Mativ Announces Third Quarter 2026 Results
Rayonier, L.P.
Rayonier, L.P.
Stabilis Solutions, Inc.
STABILIS SOLUTIONS ANNOUNCES THIRD QUARTER 2026 RESULTS
Purple Innovation, LLC
Purple Innovation Reports Third Quarter 2026 Results
Positive Operating Cash Flow for the Third Consecutive Quarter Preparing for Major Mattress Portfolio Refresh to Strengthen Performance in 2027 LEHI,…
biote Corp.
Biote Reports Third Quarter 2026 Financial Results
Company maintains 2026 financial outlook
Miller Industries, Inc.
MILLER INDUSTRIES REPORTS 2026 THIRD QUARTER RESULTS
Solid Year-Over-Year Revenue Growth Driven by Consistent Production and Demand Expanded Product Offering with Recent Introduction of 65-ton Rotator…
Snap Inc
Snap Inc. Announces Third Quarter 2026 Financial Results
Third quarter revenue increased 14% year-over-year to $1,722 million
Matson, Inc.
MATSON, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS AND RAISES FULL YEAR OUTLOOK
3Q26 EPS of $6.96 versus $4.24 in 3Q25 3Q26 Net Income of $209.4 million versus $134.7 million in 3Q25 3Q26 Consolidated Operating Income of $255.2…
HMH Holding Inc
HMH Holding Inc. Announces Third Quarter 2026 Results
Design Therapeutics, Inc.
Design Therapeutics Announces Third Quarter 2026 Financial Results and Recent Business Updates
DT-216P2 Anticipated Milestones: Registrational Plan Update in Q4 2026 and 12-Week RESTORE-FA Data in Q1 2027
agilon health, inc.
agilon health Reports Third Quarter 2026 Results
Revenue increased 6% to $1.52 billion Compared to the Same Period in the Prior Year
Vir Biotechnology, Inc.
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2026 Financial Results
- Topline data from pivotal Phase 3 ECLIPSE 1 trial expected in the fourth quarter of 2026
Aeva Technologies, Inc.
Aeva Reports Third Quarter 2026 Results
Expanded Product Portfolio in Optical Connectivity with Ultra-High Power Sources and Modules to Address Significant and Growing Demand for AI Data…